Tenofovir, Lamivudine And Efavirenz Tablets

Product/Composition Tenofovir, Lamivudine And Efavirenz Tablets
Strength 300mg + 300mg + 600mg
Form Tablets
Production Capacity 10 Million Tablets/Month
Packaging 30 Tablets/Bottle
Therapeutic use Antiviral, Anti HIV
Package Insert/Leaflet Available upon request

Tenofovir, Lamivudine, and Efavirenz Tablets are a fixed-dose combination medicine widely used in the treatment of HIV-1 infection. This single-tablet regimen simplifies therapy by combining three antiretroviral drugs.

Here are the main details:

  • Main Uses:

    • Treatment of HIV-1 infection in adults and adolescents.

    • Helps reduce viral load and increase CD4 cell counts, improving immune function.

    • Lowers the risk of HIV-related complications and transmission when used consistently with other preventive measures.

  • How It Works:

    • Tenofovir disoproxil fumarate (TDF) – a nucleotide reverse transcriptase inhibitor (NtRTI) that blocks viral replication.

    • Lamivudine (3TC) – a nucleoside reverse transcriptase inhibitor (NRTI) that interferes with viral DNA synthesis.

    • Efavirenz (EFV) – a non-nucleoside reverse transcriptase inhibitor (NNRTI) that directly blocks the reverse transcriptase enzyme.

    • Together, they provide triple antiretroviral therapy, preventing the virus from multiplying.

  • Administration:

    • Taken once daily, usually at bedtime to reduce side effects such as dizziness.

    • Should be taken on an empty stomach, as food can increase side effects of efavirenz.

    • Important to take regularly at the same time to maintain drug levels.

  • Common Side Effects:

    • Dizziness, vivid dreams, or trouble sleeping (due to efavirenz).

    • Headache, nausea, diarrhea, or fatigue.

    • Skin rash (mild to moderate).

  • Serious Concerns:

    • Liver toxicity (monitor liver function).

    • Kidney function problems (mainly from tenofovir).

    • Bone density loss (associated with tenofovir).

    • Severe depression, anxiety, or psychiatric effects (from efavirenz in some patients).

    • Lactic acidosis and enlarged liver (rare but serious).

  • Precautions:

    • Not recommended during pregnancy unless benefits outweigh risks (efavirenz may cause harm in early pregnancy).

    • Should not be combined with other medicines containing tenofovir, lamivudine, or efavirenz.

    • Caution in patients with liver disease, kidney disease, or psychiatric disorders.

    • Regular monitoring of viral load, CD4 count, kidney and liver function is necessary.

  • Storage: Keep in a cool, dry place, away from moisture and direct light.

👉 This combination is a backbone therapy in HIV management because it provides a complete regimen in a single tablet, improving adherence and long-term viral suppression.